Profound Medical Corp. (PROF)
NASDAQ: PROF · IEX Real-Time Price · USD
8.29
-0.27 (-3.15%)
May 17, 2024, 4:30 PM EDT - Market closed
Profound Medical Analyst Ratings
Total Analysts
4
Consensus Rating
Buy
Price Target
$12.60
Upside
+51.99%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $11 | Strong Buy | Maintains | $13 → $11 | +30.28% | Mar 11, 2024 |
| Stifel | Stifel | Hold Maintains $11 → $9 | Hold | Maintains | $11 → $9 | +8.56% | Mar 8, 2024 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $14 → $13 | Strong Buy | Maintains | $14 → $13 | +53.80% | Jan 4, 2024 |
| Stifel | Stifel | Hold Initiates $11 | Hold | Initiates | $11 | +32.69% | Nov 28, 2023 |
| Raymond James | Raymond James | Strong Buy → Buy Downgrades n/a | Strong Buy → Buy | Downgrades | n/a | n/a | Aug 4, 2023 |
| TD Cowen | TD Cowen | Buy Maintains $14 → $18 | Buy | Maintains | $14 → $18 | +117.13% | May 11, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $13 → $16 | Strong Buy | Maintains | $13 → $16 | +89.99% | May 11, 2023 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $5.5 → $10 | Strong Buy → Hold | Downgrades | $5.5 → $10 | +20.63% | Mar 21, 2023 |
| Raymond James | Raymond James | Buy → Strong Buy Upgrades n/a | Buy → Strong Buy | Upgrades | n/a | n/a | Nov 4, 2022 |
| Cowen & Co. | Cowen & Co. | Buy Maintains $28 → $14 | Buy | Maintains | $28 → $14 | +68.88% | Mar 7, 2022 |
| Jefferies | Jefferies | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 15, 2020 |
| Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Apr 1, 2020 |